FIELD: medicine; clinical oncology; medical genetics; molecular diagnostics.
SUBSTANCE: isolate DNA from the peripheral venous blood. Analyze polymorphisms. If TCGGCG haplotype of polymorphic loci rs3918242-rs3918249-rs17576-rs3787268-rs2250889-rs17577 of the MMP-9 gene is detected, high risk of developing breast cancer of stages 1-2 in women is predicted.
EFFECT: method provides obtaining new criteria for assessment of breast cancer stage 1-2 risk development in patients of Russian nationality, natives of the Central Black Earth region of the Russian Federation, based on data on polymorphic loci rs3918242-rs3918249-rs17576-rs3787268-rs2250889-rs17577 of the MMP-9 gene.
1 cl, 2 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RISK OF GRADE 3 MALIGNANCY OF TUMOR CELLS IN BREAST CANCER | 2023 |
|
RU2823459C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF THE LUMINAL SUBTYPE OF BREAST CANCER | 2023 |
|
RU2795720C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING BREAST CANCER IN WOMEN USING MOLECULAR GENETIC DATA | 2022 |
|
RU2795897C1 |
| METHOD FOR PREDICTION OF BREAST CANCER RISK DEVELOPMENT IN NON-OBESE WOMEN | 2023 |
|
RU2795726C1 |
| METHOD FOR PREDICTION OF BREAST CANCER RISK DEVELOPMENT IN OBESE WOMEN | 2022 |
|
RU2795244C1 |
| METHOD FOR PREDICTION OF INCREASED RISK OF DEVELOPING BREAST CANCER OF 3-4 STAGES OF DISEASE IN WOMEN | 2024 |
|
RU2830466C1 |
| METHOD FOR PREDICTING RISK OF GRADE 3 MALIGNANCY OF TUMOR CELLS IN BREAST CANCER | 2024 |
|
RU2830352C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2811257C1 |
| A METHOD FOR PREDICTING THE RISK OF DEVELOPING PEPTIC ULCER DISEASE IN WOMEN BASED ON GENETIC DATA | 2022 |
|
RU2786314C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING H. PYLORI-POSITIVE DUODENAL ULCER USING DATA ON MMP-9 GENE POLYMORPHISM | 2022 |
|
RU2782496C1 |
